Abbott NORTHAMPTON, MA / ACCESS Newswire / February 10, 2025 / Four out of 10 people living with diabetes miss appointments due to shame1. How can we change that?A lot of things we commonly hear about ...

Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.

The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive powerlift ...

We recently published a list of 15 Best Dividend Stocks To Buy and Hold. In this article, we are going to take a look at ...

Abbott (NYSE:ABT) is launching a new initiative that takes a look at some of the stigmas and stereotypes that come with ...

One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have ...

In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...

Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...

Medical device and healthcare company Abbott has opened a new facility in Kilkenny, which is expected to employ 800 people.

Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.

and STVN as the main beneficiaries following robust demand in the Continuous Glucose Monitoring (CGM) device market, as evidenced by Abbott Laboratories (NYSE:ABT)' recent growth figures. Last ...

Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc., Abbott Laboratories and ... Lingo and Libre Rio CGM devices are on a great trajectory.